Anzeige
Mehr »
Donnerstag, 04.12.2025 - Börsentäglich über 12.000 News
Einmalige Investmentchancen in den potenziellen Gamechanger der Krebsbehandlung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von RTTNews

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12:29Canadian Imperial Bank Of Commerce Profit Climbs In Q4
11:59Nutex Health Extends $25 Mln Share Buyback Program Through March 2026
11:29Laser Photonics Gets Order For Robotic Laser Cleaning Workcell
10:59Zumtobel AG Profit Climbs In Q2
10:59Polyrizon Surges On Positive Mucoadhesion Results For Naloxone Hydrogel
10:59TScan Therapeutics To Provide Update On Phase 1 Trial Of TSC-101 In Heme Malignancies Next Week
09:59Morgan Advanced Materials Targets 12% Adjusted Operating Margin By FY28
09:59Frasers Group H1 Profit Surges; Says Cautious Into H2, Backs FY26 Outlook
09:29Baltic Classifieds Group PLC Reports Increase In H1 Income
09:29UP Fintech Holding Limited Bottom Line Rises In Q3
09:29Future PLC Reports Retreat In Full Year Profit
09:29Future Earnings Decline In FY25; Guides FY26
09:29AJ Bell Plc Profit Climbs In Full Year
08:59DiscoverIE Announces Acquisition Of Trival Antene
08:29Watches Of Switzerland H1 Pretax Profit Rises; Revenue Up 10% At Constant Currency
07:59MDU Resources Prices Public Offering Of 10.15 Mln Shares At $19.70/shr
07:59Systemair AB Reports Higher Profit In Q2, Net Sales Up 4%
07:59INFICON CFO Matthias Tröndle To Step Down; Names Dimitrij Lisak Successor
07:59Addex Therapeutics Ltd Loss At -CHF1.58 Mln In Q3
07:59Aurubis FY Operating EBT Declines
07:29Formycon, MS Pharma Sign Commercialization Partnership For Keytruda Biosimilar
07:29First Majestic Prices $300 Mln Convertible Notes
06:59METRO AG Extends Contracts Of Management Board To Ensure Continuity In Transformation Process
06:29First Majestic Prices $300 Mln Convertible Notes Due 2031
06:29UiPath Stock Gains On Q3 Profit, Growth In Revenues, ARR; Issues Q4 View